A new publication titled "Chronic Kidney Disease-Associated Pruritus in Danish Dialysis Patients: A Cross-Sectional Multicenter Study of Prevalence, Disease Burden, and Current Treatment Practices" appeared on August 27, 2026. The study was published in the journal Kidney Medicine. It is described as a cross-sectional multicenter study focused on prevalence, disease burden, and current treatment practices related to pruritus in patients with chronic kidney disease who are undergoing dialysis, in Denmark. Difelikefalin, an approved compound, is associated with this area of research. No specific findings or outcomes from the study have been detailed here beyond the title and publication information provided. The publication is indexed under PubMed ID 42890303. Readers interested in the clinical and regulatory background of difelikefalin can consult the compound overview for additional context.
New Publication Examines CKD-Associated Pruritus in Danish Dialysis Patients
See the full difelikefalin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42890303/